Research Article

Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus

Volume: 8 Number: 1 April 20, 2025
  • Jean-gualbert Nève De Mévergnies
  • Marie-cécile Nollevaux
  • Philippe Eloy

Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus

Abstract

An elderly woman presented with vertigo and loss of memory. Computed tomography, positron emission tomog- raphy–computed tomography scan, and magnetic resonance imaging studies demonstrated a right ethmoid mass with evidence of bony erosion. The patient had no nasal symptoms. Endoscopy showed a polypoid mass in the right olfactive cleft. Operative biopsy wavered between benign seromucinous hamartoma and low-grade adeno- carcinoma. The patient underwent a complete excision of the mass. Final histology de!nitively proved the presence of a seromucinous hamartoma. No adverse events were noted. No adjuvant treatment was delivered. Follow-up was reassuring at 1 year.

Keywords

References

  1. Reference 1. Godse$NR, Staltari$GV, Doeden$K, Gillman$GS. Confounding case of seromuci- nous hamartoma. BMJ Case Rep. 2021;14(3):e240460. [CrossRef]
  2. Reference 2. Li$ R, Saluja$ K, Lin$ M, Hu$ Z, Cai$ Z, Zhu$ H. Sinonasal hamartomas: from Nasal chondromesenchymal hamartoma to respiratory epithelial adenomatoid hamartoma. Report of six Cases and Review of the Literature. Int J Surg Pathol. 2022;30(4):448-456. [CrossRef]
  3. Reference 3. Ban"#ková$M, Michal$M, Laco$J, et$al. Immunohistochemical and genetic analysis of respiratory epithelial adenomatoid hamartomas and seromu- cinous hamartomas: are they precursor lesions to sinonasal low-grade tubulopapillary adenocarcinomas? Hum Pathol. 2020;97:94-102. [CrossRef]
  4. 4. Tong$KN, Serra$RM, Shih$RY, Foss$RD. Seromucinous hamartoma of the nasal cavity. Head Neck Pathol. 2019;13(2):239-242. [CrossRef]
  5. 5. Fleming$ KE, Perez-Ordoñez$ B, Nasser$ JG, Psooy$ B, Bullock$ MJ. Sinonasal seromucinous hamartoma: a review of the literature and a case report with focal myoepithelial cells. Head Neck Pathol. 2012;6(3):395-399. [CrossRef]
  6. 6. Leivo$I. Sinonasal adenocarcinoma: update on classi!cation, immunophe- notype and molecular features. Head Neck Pathol. 2016;10(1):68-74. [CrossRef]
  7. 7. Jo$VY, Mills$SE, Cathro$HP, Carlson$DL, Stelow$EB. Low-grade sinonasal adeno- 10. carcinomas. The association with and distinction from respiratory epithelial adenomatoid hamartomas and other glandular lesions. Am J Surg Pathol. 2009;33(3):401-408. [CrossRef]
  8. 8. Purgina$ B, Bastaki$ JM, Duvvuri$ U, Seethala$ RR. A subset of sinonasal non- intestinal type adenocarcinomas are truly seromucinous adenocarcinomas: a 11. morphologic and immunophenotypic assessment and description of a novel pitfall. Head Neck Pathol. 2015;9(4):436-446. [CrossRef]

Details

Primary Language

English

Subjects

Allergy

Journal Section

Research Article

Authors

Jean-gualbert Nève De Mévergnies This is me
Belgium

Marie-cécile Nollevaux This is me
Belgium

Philippe Eloy This is me
Belgium

Publication Date

April 20, 2025

Submission Date

October 7, 2024

Acceptance Date

November 6, 2024

Published in Issue

Year 2025 Volume: 8 Number: 1

APA
Nève De Mévergnies, J.- gualbert, Nollevaux, M.- cécile, & Eloy, P. (2025). Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus. European Journal of Rhinology and Allergy, 8(1), 36-40. https://izlik.org/JA88EK37MZ
AMA
1.Nève De Mévergnies J gualbert, Nollevaux M cécile, Eloy P. Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus. Eur J Rhinol Allergy. 2025;8(1):36-40. https://izlik.org/JA88EK37MZ
Chicago
Nève De Mévergnies, Jean-gualbert, Marie-cécile Nollevaux, and Philippe Eloy. 2025. “Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus”. European Journal of Rhinology and Allergy 8 (1): 36-40. https://izlik.org/JA88EK37MZ.
EndNote
Nève De Mévergnies J- gualbert, Nollevaux M- cécile, Eloy P (April 1, 2025) Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus. European Journal of Rhinology and Allergy 8 1 36–40.
IEEE
[1]J.- gualbert Nève De Mévergnies, M.- cécile Nollevaux, and P. Eloy, “Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus”, Eur J Rhinol Allergy, vol. 8, no. 1, pp. 36–40, Apr. 2025, [Online]. Available: https://izlik.org/JA88EK37MZ
ISNAD
Nève De Mévergnies, Jean-gualbert - Nollevaux, Marie-cécile - Eloy, Philippe. “Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus”. European Journal of Rhinology and Allergy 8/1 (April 1, 2025): 36-40. https://izlik.org/JA88EK37MZ.
JAMA
1.Nève De Mévergnies J- gualbert, Nollevaux M- cécile, Eloy P. Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus. Eur J Rhinol Allergy. 2025;8:36–40.
MLA
Nève De Mévergnies, Jean-gualbert, et al. “Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus”. European Journal of Rhinology and Allergy, vol. 8, no. 1, Apr. 2025, pp. 36-40, https://izlik.org/JA88EK37MZ.
Vancouver
1.Jean-gualbert Nève De Mévergnies, Marie-cécile Nollevaux, Philippe Eloy. Seromucinous Hamartoma Versus Low-Grade Sinonasal Adenocarcinoma: A Worrying Mass of the Ethmoid Sinus. Eur J Rhinol Allergy [Internet]. 2025 Apr. 1;8(1):36-40. Available from: https://izlik.org/JA88EK37MZ

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.